News Astellas' Iveric takeover rewarded with FDA nod for GA drug The FDA has approved a new drug for sight-robbing disease geographic atrophy from Astellas, just a few weeks after the company
News Astellas cuts $5.9bn deal to buy Iveric Bio Astellas Pharma has agreed its largest-ever acquisition, buying US biotech Iveric Bio in a deal that continues to build its presence in the ophthalmology sector,
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
